BUZY PETER L 4
4 · Catalent, Inc. · Filed Apr 13, 2020
Insider Transaction Report
Form 4
Catalent, Inc.CTLT
BUZY PETER L
President, Gene Therapy
Transactions
- Award
Common Stock
2020-04-09$56.46/sh+266$15,018→ 45,950 total
Footnotes (2)
- [F1]Restricted stock units (RSUs) received in lieu of reporting person's receipt of certain other compensation. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on December 31, 2020.
- [F2]Includes restricted stock units.